The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation

Summary

This is a long-term intervention study on the effects of marine n-3 PUFAs in renal transplantation. Our hypothesis is that patients treated with marine n-3 PUFA supplementation will have less decline in kidney transplant function compared to patients treated with placebo.

Conditions

• Kidney Transplantation

Interventions

DRUG

Omacor

As described in "Arms".

DRUG

Placebo Oral Capsule

As described in "Arms".

Sponsors & Collaborators

• University of Oslo

  collaborator OTHER

• Rikshospitalet University Hospital

  collaborator OTHER

• Ullevaal University Hospital

  collaborator OTHER

• Drammen sykehus

  collaborator OTHER

• Elverum Hospital

  collaborator UNKNOWN

• South-Eastern Norway Regional Health Authority

  collaborator OTHER

• Aalborg University Hospital

  collaborator OTHER

• Pronova BioPharma

  collaborator INDUSTRY

• Haukeland University Hospital

  collaborator OTHER

• University Hospital of North Norway

  collaborator OTHER

• Joe Chan

  lead OTHER

Principal Investigators

• My Svensson, MD, PhD · University Hospital, Akershus

• Ivar Anders Eide, MD, PhD · University Hospital, Akershus

• Branimir Draganov, MD · Ullevaal University Hospital

• Joe Chan, MD · University Hospital, Akershus

• Morten Reier-Nilsen, MD · Drammen sykehus

• Tone Granseth, MD · Elverum Hospital

• Nanna von der Lippe, MD, PhD · Ullevaal University Hospital

• Bård Endre Waldum-Grevbo, MD, PhD · Ullevaal University Hospital

• Per Olav Rui, MD · Haukeland University Hospital

• Toralf Melsom, MD, PhD · University Hospital of North Norway

• Renathe Rismo, MD, PhD · University Hospital of North Norway

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2017-09-01

Primary Completion

2024-03-22

Completion

2025-03-22

Countries

• Norway

Study Locations